Part 1
Part 2
Part 3
Part 5
Description
Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease. The global market for Rheumatoid Arthritis Testing was estimated to be worth US$ 2008.4 million in 2023 and is forecast to a readjusted size of US$ 3487 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030
Rheumatoid Arthritis Testing Market Size
M= millions and B=billions
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rheumatoid Arthritis Testing by region & country, by Type, and by Application.
The Rheumatoid Arthritis Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Testing.
Market Segmentation
Report Metric
Details
Report Title
Rheumatoid Arthritis Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 3487 million
CAGR(2024-2030)
7%
Market Size Available for Years
2019-2030
Global Rheumatoid Arthritis Testing Companies Covered
Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, Augurex Life Sciences, Svar Life Science AB, Aviva Systems Biology, Bio-Rad Laboratories, Thermo Fisher Scientific, Microdrop, Werfen, Axis-Shield
Global Rheumatoid Arthritis Testing Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rheumatoid Arthritis Testing Market, Segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others
Global Rheumatoid Arthritis Testing Market, Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rheumatoid Arthritis Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Rheumatoid Arthritis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Rheumatoid Arthritis Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Rheumatoid Arthritis Testing Product Introduction
1.2 Global Rheumatoid Arthritis Testing Market Size Forecast
1.3 Rheumatoid Arthritis Testing Market Trends & Drivers
1.3.1 Rheumatoid Arthritis Testing Industry Trends
1.3.2 Rheumatoid Arthritis Testing Market Drivers & Opportunity
1.3.3 Rheumatoid Arthritis Testing Market Challenges
1.3.4 Rheumatoid Arthritis Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rheumatoid Arthritis Testing Players Revenue Ranking (2023)
2.2 Global Rheumatoid Arthritis Testing Revenue by Company (2019-2024)
2.3 Key Companies Rheumatoid Arthritis Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rheumatoid Arthritis Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Rheumatoid Arthritis Testing
2.6 Rheumatoid Arthritis Testing Market Competitive Analysis
2.6.1 Rheumatoid Arthritis Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Rheumatoid Arthritis Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Serological Tests
3.1.2 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
3.1.3 Imaging Tests
3.1.4 Others
3.2 Global Rheumatoid Arthritis Testing Sales Value by Type
3.2.1 Global Rheumatoid Arthritis Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rheumatoid Arthritis Testing Sales Value, by Type (2019-2030)
3.2.3 Global Rheumatoid Arthritis Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Diagnostic Centers
4.1.3 Others
4.2 Global Rheumatoid Arthritis Testing Sales Value by Application
4.2.1 Global Rheumatoid Arthritis Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rheumatoid Arthritis Testing Sales Value, by Application (2019-2030)
4.2.3 Global Rheumatoid Arthritis Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Rheumatoid Arthritis Testing Sales Value by Region
5.1.1 Global Rheumatoid Arthritis Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rheumatoid Arthritis Testing Sales Value by Region (2019-2024)
5.1.3 Global Rheumatoid Arthritis Testing Sales Value by Region (2025-2030)
5.1.4 Global Rheumatoid Arthritis Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.2.2 North America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.3.2 Europe Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.5.2 South America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rheumatoid Arthritis Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rheumatoid Arthritis Testing Sales Value
6.3 United States
6.3.1 United States Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.3.2 United States Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.4.2 Europe Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.5.2 China Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.6.2 Japan Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.7.2 South Korea Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.9.2 India Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
7.1.4 Abbott Laboratories Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Profile
7.2.2 F. Hoffmann-La Roche Main Business
7.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Products, Services and Solutions
7.2.4 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.2.5 F. Hoffmann-La Roche Recent Developments
7.3 Beckman Coulter
7.3.1 Beckman Coulter Profile
7.3.2 Beckman Coulter Main Business
7.3.3 Beckman Coulter Rheumatoid Arthritis Testing Products, Services and Solutions
7.3.4 Beckman Coulter Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Siemens Healthineers Recent Developments
7.4 Siemens Healthineers
7.4.1 Siemens Healthineers Profile
7.4.2 Siemens Healthineers Main Business
7.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Products, Services and Solutions
7.4.4 Siemens Healthineers Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Siemens Healthineers Recent Developments
7.5 Augurex Life Sciences
7.5.1 Augurex Life Sciences Profile
7.5.2 Augurex Life Sciences Main Business
7.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Products, Services and Solutions
7.5.4 Augurex Life Sciences Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Augurex Life Sciences Recent Developments
7.6 Svar Life Science AB
7.6.1 Svar Life Science AB Profile
7.6.2 Svar Life Science AB Main Business
7.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Products, Services and Solutions
7.6.4 Svar Life Science AB Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Svar Life Science AB Recent Developments
7.7 Aviva Systems Biology
7.7.1 Aviva Systems Biology Profile
7.7.2 Aviva Systems Biology Main Business
7.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Products, Services and Solutions
7.7.4 Aviva Systems Biology Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Aviva Systems Biology Recent Developments
7.8 Bio-Rad Laboratories
7.8.1 Bio-Rad Laboratories Profile
7.8.2 Bio-Rad Laboratories Main Business
7.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
7.8.4 Bio-Rad Laboratories Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Rad Laboratories Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Profile
7.9.2 Thermo Fisher Scientific Main Business
7.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Products, Services and Solutions
7.9.4 Thermo Fisher Scientific Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Microdrop
7.10.1 Microdrop Profile
7.10.2 Microdrop Main Business
7.10.3 Microdrop Rheumatoid Arthritis Testing Products, Services and Solutions
7.10.4 Microdrop Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Microdrop Recent Developments
7.11 Werfen
7.11.1 Werfen Profile
7.11.2 Werfen Main Business
7.11.3 Werfen Rheumatoid Arthritis Testing Products, Services and Solutions
7.11.4 Werfen Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Werfen Recent Developments
7.12 Axis-Shield
7.12.1 Axis-Shield Profile
7.12.2 Axis-Shield Main Business
7.12.3 Axis-Shield Rheumatoid Arthritis Testing Products, Services and Solutions
7.12.4 Axis-Shield Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Axis-Shield Recent Developments
8 Industry Chain Analysis
8.1 Rheumatoid Arthritis Testing Industrial Chain
8.2 Rheumatoid Arthritis Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rheumatoid Arthritis Testing Sales Model
8.5.2 Sales Channel
8.5.3 Rheumatoid Arthritis Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Rheumatoid Arthritis Testing Market Trends
Table 2. Rheumatoid Arthritis Testing Market Drivers & Opportunity
Table 3. Rheumatoid Arthritis Testing Market Challenges
Table 4. Rheumatoid Arthritis Testing Market Restraints
Table 5. Global Rheumatoid Arthritis Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Rheumatoid Arthritis Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Rheumatoid Arthritis Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Rheumatoid Arthritis Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Rheumatoid Arthritis Testing
Table 10. Global Rheumatoid Arthritis Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Rheumatoid Arthritis Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Rheumatoid Arthritis Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Rheumatoid Arthritis Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Rheumatoid Arthritis Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Rheumatoid Arthritis Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Rheumatoid Arthritis Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Rheumatoid Arthritis Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Rheumatoid Arthritis Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Rheumatoid Arthritis Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Rheumatoid Arthritis Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Rheumatoid Arthritis Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. F. Hoffmann-La Roche Basic Information List
Table 37. F. Hoffmann-La Roche Description and Business Overview
Table 38. F. Hoffmann-La Roche Rheumatoid Arthritis Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of F. Hoffmann-La Roche (2019-2024)
Table 40. F. Hoffmann-La Roche Recent Developments
Table 41. Beckman Coulter Basic Information List
Table 42. Beckman Coulter Description and Business Overview
Table 43. Beckman Coulter Rheumatoid Arthritis Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Beckman Coulter (2019-2024)
Table 45. Beckman Coulter Recent Developments
Table 46. Siemens Healthineers Basic Information List
Table 47. Siemens Healthineers Description and Business Overview
Table 48. Siemens Healthineers Rheumatoid Arthritis Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Siemens Healthineers (2019-2024)
Table 50. Siemens Healthineers Recent Developments
Table 51. Augurex Life Sciences Basic Information List
Table 52. Augurex Life Sciences Description and Business Overview
Table 53. Augurex Life Sciences Rheumatoid Arthritis Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Augurex Life Sciences (2019-2024)
Table 55. Augurex Life Sciences Recent Developments
Table 56. Svar Life Science AB Basic Information List
Table 57. Svar Life Science AB Description and Business Overview
Table 58. Svar Life Science AB Rheumatoid Arthritis Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Svar Life Science AB (2019-2024)
Table 60. Svar Life Science AB Recent Developments
Table 61. Aviva Systems Biology Basic Information List
Table 62. Aviva Systems Biology Description and Business Overview
Table 63. Aviva Systems Biology Rheumatoid Arthritis Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Aviva Systems Biology (2019-2024)
Table 65. Aviva Systems Biology Recent Developments
Table 66. Bio-Rad Laboratories Basic Information List
Table 67. Bio-Rad Laboratories Description and Business Overview
Table 68. Bio-Rad Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Bio-Rad Laboratories (2019-2024)
Table 70. Bio-Rad Laboratories Recent Developments
Table 71. Thermo Fisher Scientific Basic Information List
Table 72. Thermo Fisher Scientific Description and Business Overview
Table 73. Thermo Fisher Scientific Rheumatoid Arthritis Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Thermo Fisher Scientific (2019-2024)
Table 75. Thermo Fisher Scientific Recent Developments
Table 76. Microdrop Basic Information List
Table 77. Microdrop Description and Business Overview
Table 78. Microdrop Rheumatoid Arthritis Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Microdrop (2019-2024)
Table 80. Microdrop Recent Developments
Table 81. Werfen Basic Information List
Table 82. Werfen Description and Business Overview
Table 83. Werfen Rheumatoid Arthritis Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Werfen (2019-2024)
Table 85. Werfen Recent Developments
Table 86. Axis-Shield Basic Information List
Table 87. Axis-Shield Description and Business Overview
Table 88. Axis-Shield Rheumatoid Arthritis Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Axis-Shield (2019-2024)
Table 90. Axis-Shield Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Rheumatoid Arthritis Testing Downstream Customers
Table 94. Rheumatoid Arthritis Testing Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Rheumatoid Arthritis Testing Product Picture
Figure 2. Global Rheumatoid Arthritis Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Rheumatoid Arthritis Testing Report Years Considered
Figure 5. Global Rheumatoid Arthritis Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Rheumatoid Arthritis Testing Revenue in 2023
Figure 7. Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Serological Tests Picture
Figure 9. Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests Picture
Figure 10. Imaging Tests Picture
Figure 11. Others Picture
Figure 12. Global Rheumatoid Arthritis Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Rheumatoid Arthritis Testing Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospitals and Clinics
Figure 15. Product Picture of Diagnostic Centers
Figure 16. Product Picture of Others
Figure 17. Global Rheumatoid Arthritis Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Rheumatoid Arthritis Testing Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value (%), (2019-2030)
Figure 30. United States Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
Figure 36. China Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
Figure 38. China Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
Figure 48. India Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
Figure 50. India Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
Figure 51. Rheumatoid Arthritis Testing Industrial Chain
Figure 52. Rheumatoid Arthritis Testing Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Description
Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease. The global market for Rheumatoid Arthritis Testing was estimated to be worth US$ 2008.4 million in 2023 and is forecast to a readjusted size of US$ 3487 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rheumatoid Arthritis Testing by region & country, by Type, and by Application.
The Rheumatoid Arthritis Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Testing.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rheumatoid Arthritis Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Rheumatoid Arthritis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Rheumatoid Arthritis Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now